Boston Trust Walden Corp cut its stake in shares of Amcor PLC (NYSE:AMCR – Free Report) by 7.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 136,269 shares of the company’s stock after selling 11,500 shares during the quarter. Boston Trust Walden Corp’s holdings in Amcor were worth $1,252,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. AdvisorNet Financial Inc boosted its stake in shares of Amcor by 839.8% during the second quarter. AdvisorNet Financial Inc now owns 3,026 shares of the company’s stock valued at $28,000 after purchasing an additional 2,704 shares in the last quarter. Rakuten Securities Inc. raised its position in Amcor by 18,725.0% during the 1st quarter. Rakuten Securities Inc. now owns 3,012 shares of the company’s stock worth $29,000 after purchasing an additional 2,996 shares during the last quarter. Adirondack Trust Co. bought a new position in Amcor during the 2nd quarter worth $29,000. HM Payson & Co. bought a new position in Amcor during the 1st quarter worth $30,000. Finally, Brentview Investment Management LLC bought a new position in Amcor during the 1st quarter worth $31,000. 45.14% of the stock is owned by institutional investors.
Insiders Place Their Bets
In related news, Director Stephen E. Sterrett purchased 10,000 shares of the firm’s stock in a transaction dated Tuesday, August 19th. The shares were purchased at an average cost of $8.55 per share, for a total transaction of $85,500.00. Following the completion of the transaction, the director directly owned 10,000 shares in the company, valued at approximately $85,500. This represents a ∞ increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.32% of the stock is owned by insiders.
Analyst Upgrades and Downgrades
View Our Latest Analysis on AMCR
Amcor Trading Down 0.7%
Shares of AMCR stock opened at $8.05 on Thursday. The company has a 50 day moving average of $8.44 and a 200-day moving average of $9.02. The company has a quick ratio of 0.71, a current ratio of 1.21 and a debt-to-equity ratio of 1.18. Amcor PLC has a 12-month low of $7.81 and a 12-month high of $11.38. The firm has a market cap of $18.55 billion, a P/E ratio of 22.35, a PEG ratio of 1.16 and a beta of 0.73.
Amcor (NYSE:AMCR – Get Free Report) last issued its earnings results on Thursday, August 14th. The company reported $0.20 earnings per share for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.01). The business had revenue of $5.08 billion for the quarter, compared to the consensus estimate of $5.18 billion. Amcor had a return on equity of 19.43% and a net margin of 3.40%.Amcor’s revenue for the quarter was up 43.8% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.21 EPS. Amcor has set its FY 2026 guidance at 0.800-0.830 EPS. Sell-side analysts anticipate that Amcor PLC will post 0.74 earnings per share for the current year.
Amcor Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Friday, September 5th were paid a $0.1275 dividend. The ex-dividend date was Friday, September 5th. This represents a $0.51 annualized dividend and a yield of 6.3%. Amcor’s dividend payout ratio (DPR) is currently 141.67%.
About Amcor
Amcor plc develops, produces, and sells packaging products in Europe, North America, Latin America, Africa, and the Asia Pacific regions. The company operates through two segments, Flexibles and Rigid Packaging. The Flexibles segment provides flexible and film packaging products in the food and beverage, medical and pharmaceutical, fresh produce, snack food, personal care, and other industries.
Read More
- Five stocks we like better than Amcor
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Are Dividend Challengers?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- 3 Tickers Leading a Meme Stock Revival
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Want to see what other hedge funds are holding AMCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amcor PLC (NYSE:AMCR – Free Report).
Receive News & Ratings for Amcor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amcor and related companies with MarketBeat.com's FREE daily email newsletter.